Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

The new class of weight-loss drugs are being tested as cure-alls for everything from knee replacements to liver disease and throwing corners of the stock market into disarray.

Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea StocksBitcoin Funds See Most Outflows Over Two Weeks Since ETF ApprovalChina Floats Perks for German Carmakers in Bid to Stop EV LeviesSri Lanka Set to Start Next Round of Investor Talks This WeekCitrus Exporter South Africa Asks WTO for Dispute Panels With EUNvidia enters correction territory as slump erases US$400 billionFrench Banks Still Solid Despite Election Selloff, Villeroy SaysHow listing a trusted contact could foil financial...

1 Billion PIK to Apex GroupRecord Labels Sue Two Startups for Training AI Models on Their SongsCar Sellers Warn Investors of Possible Financial Hit From CyberattackDeveloper of London’s World War II Tunnels to List in AmsterdamBitcoin Funds See Most Outflows Over Two Weeks Since ETF ApprovalChina Floats Perks for German Carmakers in Bid to Stop EV LeviesSri Lanka Set to Start Next Round of Investor Talks This WeekKuwait Finance House Explores Bid for Stake in Saudi Investment BankEU Sanctions...

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 83. in BR

Brasil Últimas Notícias, Brasil Manchetes